Evaluation of the effect of nelfinavir on QT intervals at steady-state after twice-daily administration of nelfinavir tablets to healthy volunteers

Trial Profile

Evaluation of the effect of nelfinavir on QT intervals at steady-state after twice-daily administration of nelfinavir tablets to healthy volunteers

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Apr 2009

At a glance

  • Drugs Nelfinavir (Primary)
  • Indications HIV infections
  • Focus Pharmacodynamics
  • Sponsors Pfizer
  • Most Recent Events

    • 14 Apr 2009 Planned end date 1 Jun 2006 added as reported by ClinicalTrials.gov
    • 22 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top